Anticancer drug | Dropping amount (μg) | No sheet | Control sheet 1 | Control sheet 2 | HD safe Sheet-U |
---|---|---|---|---|---|
CPA | 2000 | 367.8 ± 16.3 | 355.3 ± 59.0 | 256.3 ± 44.3** | ND |
IFM | 1000 | 142.4 ± 26.8 | 32.5 ± 3.3 | 21.2 ± 2.2*** | 16.8 ± 2.1*** † |
CBDCA | 5000 | 275.2 ± 56.7 | 16.1 ± 5.0 | 11.9 ± 3.7 | 1.5 ± 0.5*** †† |
CDDP | 100 | 0.7 ± 0.2 | 0.3 ± 0.1 | 0.3 ± 0.1 | 0.2 ± 0.1* |
MTX | 6000 | 1183.1 ± 130.6 | 78.0 ± 6.4 | 53.6 ± 7.8*** | 5.0 ± 1.6*** ††† |
5-FU | 1000 | 88.1 ± 9.1 | 5.1 ± 1.3 | 4.0 ± 0.3 | 3.8 ± 0.1 |
Ara-C | 1000 | 137.4 ± 51.5 | 45.3 ± 15.8 | 3.1 ± 1.1*** | LOQ |
GEM | 300 | 45.8 ± 8.5 | 27.4 ± 5.4 | 1.5 ± 0.1 | LOQ |
ADR | 1000 | 198.7 ± 30.9 | 25.9 ± 3.7 | 7.7 ± 1.6*** | LOQ |
Epi-ADR | 1000 | 8.8 ± 0.8 | 0.7 ± 0.2 | 0.9 ± 0.2*** | 0.6 ± 0.2 |
PTX | 200 | 27.6 ± 9.5 | LOQ | LOQ | LOQ |
DTX | 200 | 34.2 ± 7.1 | 2.7 ± 1.8 | 0.5 ± 0.0* | ND |
VP-16 | 500 | 118.2 ± 29.5 | 3.4 ± 1.4 | 1.5 ± 0.7* | 0.6 ± 0.1* |
CPT-11 | 1500 | 63.9 ± 34.5 | LOQ | LOQ | LOQ |